Concepedia
Statistics
Publications
20
Citations
867
H-Index
16
Active since
2012
Affiliations
Weizmann Institute of Science(Current)
Heidelberg University
German Cancer Research Center
Tel Aviv University
Sheba Medical Center
Nishanth Belugali Nataraj is an author at Weizmann Institute of Science specializing in medicine, cell biology, and tumor biology.
Top concepts
MedicineCell BiologyTumor BiologyCancer BiologyRadiation OncologyCancer ResearchOncologyPathologyCell SignalingCancer Cell Biology
Publications per year
2012–2023
<i>TP53</i> missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironment
Martino Maddalena, Giuseppe Mallel, Nishanth Belugali Nataraj et al. · Proceedings of the National Academy of Sciences · 2021 · 111 citations · Full text
Altered p53 functionality in cancer-associated fibroblasts contributes to their cancer-supporting features
Sharathchandra Arandkar, Noa Furth, Yair Elisha et al. · Proceedings of the National Academy of Sciences · 2018 · 109 citations · Full text
Tumor Biology, Oncology, Medicine +15
Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patients
Ori Hassin, Nishanth Belugali Nataraj, Michal Shreberk‐Shaked et al. · Nature Communications · 2022 · 97 citations · Full text
Engineering, Pathology, Cancer Biology +18
AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer
Ashish Noronha, Nishanth Belugali Nataraj, Joo Sang Lee et al. · Cancer Discovery · 2022 · 94 citations · Full text
Proteomic patterns associated with response to breast cancer neoadjuvant treatment
Anjana Shenoy, Nishanth Belugali Nataraj, Gili Perry et al. · Molecular Systems Biology · 2020 · 67 citations · Full text
1–5 of 20